Summary: Leading Market Research Firm, the Brightfield Group, Ranks Paw CBD in Top 5 CBD Pet Brands in America, and Reports the CBD Pet Market Grew 950% YOY In 2019
“Paw CBD and its award-winning products have evolved into a trusted standalone brand and it’s important that we provide an online experience tailored specifically to pet lovers. Paw CBD products were originally offered through the flagship cbdMD retail website, but with the rapid expansion of the Paw CBD product line and continued reach into retail stores, the need for a branded destination website was critical to keep up with growth,” said Paul DiBrito, leader of the Paw CBD brand.
“We are also pleased that the Brightfield Group ranked Paw CBD as a top 5 CBD pet brand in America. The Brightfield Groups recently released Pet Parent Profile showed that Americans spent an estimated $321 million on CBD pet products in 2019, an incredible jump of over 950% from the estimated $31 million spent in 2018. We expect continued growth in the CBD pet market in 2020 and Paw CBD is very well positioned to gain more market share in this rapidly growing market,” said DiBrito.
Alongside Paw CBD’s extensive product line, the new website features educational materials intended to help consumers better understand CBD and its many applications for dogs, cats, and horses. Paw CBD customers will also continue to have access to cbdMD’s top rated customer service team.
1 Paw CBD pet products, please visit pawcbd.com or follow Paw CBD on Instagram and Facebook.’ data-reactid=”25″>Paw CBD is the pet division of cbdMD whose veterinarian-formulated products include tinctures, chews, and topicals in varying strengths and formulas. Paw CBD is a proud supporter of Project 2 Heal and the Humane Society of Charlotte. To learn more about the comprehensive line of THC-free1 Paw CBD pet products, please visit pawcbd.com or follow Paw CBD on Instagram and Facebook.
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ″should,″ ″may,″ ″intends,″ ″anticipates,″ ″believes,″ ″estimates,″ ″projects,″ ″forecasts,″ ″expects,″ ″plans,″ and ″proposes.″ These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the Securities and Exchange Commission (the “SEC”), and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.[email protected]
1 (800) 973-3984